Statement by FDA Commissioner on Opioid Access for Patients With Chronic and End-of-Life Pain

July 12, 2018 – The opioid epidemic continues to take an emotional, physical, and financial toll on Americans. The FDA is committed to taking every possible step to address the many facets of this complex public health crisis. While we work to ensure appropriate and rational prescribing of opioids, we won’t lose sight of the needs of Americans living with serious chronic pain or coping with pain at the end of life. They too face significant challenges. So, as we consider new … (leggi tutto)